首页> 美国卫生研究院文献>British Journal of Cancer >Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute Milan G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

【2h】

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute Milan G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

机译：比较铂类化疗后晚期卵巢癌晚期患者中单药紫杉醇与依多柔比星加紫杉醇的随机对照试验：一项来自意大利米兰市 Mario Negri研究所的意大利合作研究（Gruppo Oncologico Nord Ovest）组和I.O.R. （Istituto Oncologico Romagnolo）组

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 British Journal of Cancer
作者
A Buda; I Floriani; R Rossi; N Colombo; V Torri; P F Conte; R Fossati; A Ravaioli; C Mangioni;
展开▼
作者单位

展开▼
年(卷),期 2004(90),11
年度 2004
页码 2112–2117
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
randomised trial early progression chemotherapy recurrent ovarian cancer;

机译：随机试验;早期进展;化疗;复发性卵巢癌;

相似文献

外文文献

1. Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the |[lsquo]|Mario Negri|[rsquo]| Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group [J] . A Buda, I Floriani, R Rossi, British Journal of Cancer . 2004,第11期

机译：比较单药紫杉醇与依多柔比星加紫杉醇在铂类化疗后早期进展的晚期卵巢癌患者中的一项随机对照试验：意大利研究[|] | Mario Negri | [|]米兰研究所（Gruppo Oncologico Nord Ovest）组和I.O.R. （Istituto Oncologico Romagnolo）组
2. 599 ORAL Improved activity with irinotecan, oxaliplatin and infusional 5-FU/LV (FOLFOXIRI) compared with FOLFIRI in metastatic colorectal cancer (MCRC): results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.) [J] . European Journal of Cancer Supplements . 2005,第2期

机译：599 ORAL与FOLFIRI相比，伊立替康，奥沙利铂和5-FU / LV输注（FOLFOXIRI）在转移性结直肠癌（MCRC）中的活性提高：Gruppo Oncologico Nord Ovest（G.O.N.O.）进行的一项随机III期试验的结果
3. High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest. [J] . Conte PF, Bruzzone M, Carnino F, Journal of Clinical Oncology . 1996,第2期

机译：次优卵巢癌中大剂量与小剂量顺铂联合环磷酰胺和表阿霉素的治疗：对Gruppo Oncologico Nord-Ovest的随机研究。
4. Comparing Docetaxel Plus Cisplatin with Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer: a Single Institute Study [O] . Kian Khodadad, Adnan Khosravi, Zahra Esfahani-Monfared, 2014

机译：一项单机构研究比较未接受化疗的单纯化疗的多西他赛加顺铂与紫杉醇加卡铂在未接受化疗的患者中的比较
5. Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group [O] . Buda, A, Floriani, I, Rossi, R, 2004

机译：比较铂类化疗后晚期卵巢癌晚期患者中单药紫杉醇与依多柔比星加紫杉醇的随机对照试验：一项来自意大利米兰市“ Mario Negri”研究所的意大利合作研究（Gruppo Oncologico Nord Ovest）组和I.O.R. （Istituto Oncologico Romagnolo）组

著录项

相似文献

相关主题

期刊订阅